BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ClinPharm Consulting CEO, Geoffrey Banks, Ph.D., Presenting at Triangle Biotech Research Symposium


8/16/2012 11:45:21 AM

(Research Triangle Park, N.C.) Geoffrey Banks, Ph.D., CEO of the pharmaceutical industry’s go-to resource for pharmacokinetics (PK), ClinPharm Consulting, will be presenting on biosimilars at the inaugural Triangle Research Symposium August 21st 2012.

Dr. Banks will be delivering “What’s Up with the Term ‘Similar’ in Biosimilar? The Evolution of Biosimilars Science and Regulatory Policy” during the event at the NC Biotech Center in RTP.

“While biosimilar policy and science is still in its infancy, interesting trends have emerged in the evolution of this field in the pharmaceutical industry” Dr. Banks explained.

The presentation will also review the use of “similar” to describe generic copies of biologics, how the term has penetrated the pharmaceutical industry lexicon, and ask why can’t there be a “biogeneric”.

In crafting his presentation, Dr. Banks utilized his knowledge of biologics gained through doctorate and post-doctoral research in protein biochemistry and molecular biology in addition to pharmacokinetic drug development conducted on biologics as CEO of ClinPharm. ClinPharm helps clients navigate through the complex drug development process to marketing approval by taking a common sense approach based on scientific principles to provide excellence in PK and clinical pharmacology.

Focusing on the action and use of drugs in human clinical studies supporting overall marketing applications to regulatory authorities, ClinPharm looks at drug-drug interactions, cardiac conduction (thorough QT), first time in human safety and PK, single and multiple dose effects, hepatic and renal impairment on drug action, among other clinical pharmacology and PK issues. Services ClinPharm provides include pharmacokinetic analysis, pharmacodynamic analysis, and PK/PD analysis; strategic planning (program strategy, regulatory strategy, etc.); authoring integrated clinical/PK/PD study reports; and standalone PK/PD reports.

“Our common sense, ‘less is more’ philosophy provides companies with useable clinical pharmacology and PK advice from leading scientists and pharmacokineticists,” Chief Operating Officer M. Alexander Shaw, Ph.D., said.

Dr. Shaw points to organic growth at ClinPharm, such as the recent addition of accomplished pharmacokinetic and drug development consultant David Y. Mitchell, Ph.D., (Current President of the American Association of Pharmaceutical Scientists [AAPS]) as an example of the company’s commitment to meeting client needs with a team of seasoned consultants to provide a greater level of service and support.

Dr. Banks will be available at the August 21st Research Symposium to answer questions about the company and its services. The Symposium will focus on the theme of "Biotech Innovation in the Triangle” with over a dozen invited companies providing energetic and informative discussions centering around research, development, diagnostics and other topics.

For more information on ClinPharm’s integrated, flexible PK and clinical pharmacology outsourcing options visit www.clinpharmconsulting.com.

About ClinPharm Consulting

ClinPharm Consulting, LLC is a clinical pharmacology consulting firm specializing in pharmacokinetics (PK). Fast becoming the pharmaceutical industry’s go-to resource for PK, ClinPharm gives pharmaceutical companies and CROs rare access to a hands-on team of leading clinical pharmacology and PK professionals experienced in a multitude of therapeutic areas. We embrace the notion that simplicity and clarity lead to good decisions by taking complex PK principals and making them understandable and usable for common sense drug development. ClinPharm’s flexible business structure enables us to integrate with our clients and help them maximize the potential of clinical pharmacology studies and PK analyses to pave the way toward marketing approval. For more information visit www.clinpharmconsulting.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES